Shree Ram Proteins Limited EOGM Approves Sale of Undertaking and Capital Raise
Shree Ram Proteins Limited held an EOGM on March 05, 2026. Shareholders approved the sale of an undertaking as a related party transaction and authorized capital raising via Qualified Institutions Placement (QIP). Both resolutions received strong majority support from shareholders.
The approval for selling an undertaking and raising capital through QIP can have a significant impact on the company's financial structure and future business strategy.
The company successfully passed two key resolutions related to business operations and capital raising with strong shareholder support, indicating positive progress and confidence.
Shree Ram Proteins Limited held its Extra Ordinary General Meeting (EOGM) on March 05, 2026, through Video Conferencing (VC). The meeting, which commenced at 3:30 p.m. IST, was conducted in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013.
During the EOGM, two Ordinary Resolutions were put forth for shareholder approval. The first resolution concerned the sale of an undertaking of the company as a material related party transaction, falling under Section 188 of the Companies Act, 2013, and Regulation 23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This resolution received overwhelming support, with 100% of the votes polled in favor from both Promoter and Promoter Group, and Public-Non Institutions.
The second resolution addressed the company's plan to raise capital through a Qualified Institutions Placement (QIP) by issuing equity shares and/or other eligible securities. This resolution also garnered strong approval, with 99.91% of the total votes polled in favor. Promoter and Promoter Group cast their votes entirely in favor, while Public-Non Institutions showed significant support with 99.80% of their votes in favor.
The voting results, including remote e-voting and e-voting during the EOGM, were consolidated and reported by CS Payal Dhamecha, Practicing Company Secretary. The total number of shareholders on the record date was 41,943. The company's Chairman and Managing Director, Lalitkumar Chandulal Vasoya, was present at the meeting.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.